Assessment to Intervention: Tech innovation in Adult & Paediatric eating, drinking and swallowing

Tech Shift in Swallowing Care

Eating, drinking, and swallowing difficulties—known clinically as dysphagia—affect millions, particularly older adults post-stroke or with neurological conditions, and children with developmental disorders. These issues lead to risks including choking, malnutrition, dehydration, and recurrent pneumonia, driving up healthcare costs and diminishing quality of life.

Recent years have seen accelerated technological progress. Systematic reviews from 2025 highlight AI and sensor-based tools, including machine learning models and wearables, achieving high accuracy in detecting aspiration risks and classifying swallows from video or depth data. Deep learning approaches are emerging to automate analysis of instrumental assessments like videofluoroscopy, potentially reducing diagnostic delays and subjectivity.

Specific innovations include pharyngeal electrical stimulation to strengthen swallow muscles in adults, and high-resolution manometry providing detailed pressure data to guide precise interventions for both adults and children. Market analyses project the global dysphagia management sector growing from around $5.6 billion in 2024 to $7.4 billion by 2030, fuelled by these non-invasive tech advances and demand in oncology, post-stroke care, and palliative settings.

In the UK, the Royal College of Speech and Language Therapists (RCSLT) published revised guidance in March 2025, shifting terminology from 'dysphagia' to 'eating, drinking and swallowing' (EDS) to reflect a lifespan approach. This update, accompanied by a new competency framework for therapists, responds to evolving practice needs and aligns with tools like the International Dysphagia Diet Standardisation Initiative (IDDSI) for consistent texture-modified diets.

The timing coincides with broader demographic pressures—an ageing population increases dysphagia incidence—and heightened awareness efforts, including Swallowing Awareness Day 2026. Yet non-obvious tensions persist: while AI promises scalable screening, methodological quality in studies varies, and adoption faces barriers in resource-limited settings. Paediatric applications lag behind adult ones, with evidence still emerging for tools like FEES (fibreoptic endoscopic evaluation of swallowing) enhancements in children.

The stakes are tangible. Untreated or poorly managed dysphagia contributes to thousands of preventable hospital admissions annually in the UK alone, with aspiration pneumonia carrying high mortality in vulnerable groups. Effective tech integration could cut these burdens, but requires balancing innovation speed against rigorous validation and equitable access.